Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Atlys raises $12m in Series A round to revolutionize visa applications Atlys, a digital platform specializing in visa applications, has garnered $12 million in a Series A funding round.… byPallavi MadhirajuSeptember 21, 2023